Health
FDA's Rick Pazdur on Agency Restructuring Amid Competition
Rick Pazdur, acting director of the FDA’s Office of Drug Evaluation, discussed the agency’s challenges and potential restructuring amid increased competition from other health agencies.
Coverage timeline — 1 article
STAT News
Rick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as…
2026-05-30 15:48 UTC